SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Sanchez I. As tetraciclinas no tratamento da artrite reumatoid e doencas reumaticas inflamatorias. [Tetracycline treatment in RA and other rheumatic diseases]. Brasil Med 1968; 82: 2231.
  • 2
    Brown TM, Hochberg MC, Hicks JT, Clark HW. Antibiotic therapy of RA: a retrospective cohort study of 98 patients with 451 patient-years of follow-up. Int Congr Rheumatol 1985; S8: 5.
  • 3
    Breedveld FC, Dijkmans BAC, Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol 1990; 17: 436.
  • 4
    Langevitz P, Bank I, Zemer D, Book M, Pras M. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol 1992; 19: 15024.
  • 5
    Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BAC. Minocycline in active rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum 1994; 37: 62936.
  • 6
    Tiley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al. Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995; 122: 819.
  • 7
    Alarcon GS. Tetracyclines in the treatment of rheumatoid arthritis: they work, but we do not know the reason(s). J Clin Rheumatol 1995; 1: 1903.
  • 8
    Greenwald RA. Tetracyclines may be therapeutically beneficial in rheumatoid arthritis, but not for the reasons that you might think. J Clin Rheumatol 1995; 1: 1859.
  • 9
    Van der Heide A, Jacobs JWG, Bijlsma JWJ, Heurkens AHM, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996; 124: 699707.
  • 10
    O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997; 40: 8428.
  • 11
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 12
    Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990; 33: 47784.
  • 13
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968; 37: 393406.
  • 14
    Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 130815.
  • 15
    Alarcon GS, Blackburn WD Jr, Calvo A, Castaneda O. Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study. J Rheumatol 1987; 14: 936.
  • 16
    O'Dell JR. Combination DMARD therapy for rheumatoid arthritis: apparent universal acceptance [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S50.
  • 17
    Greenwald RA. Treatment of destructive arthritic disorders with MMP inhibitors: potential role of tetracyclines. Ann N Y Acad Sci 1994; 732: 18198.
  • 18
    Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen ameliorate bone damage. J Rheumatol 1992; 19: 92738.
  • 19
    Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992; 35: 11509.
  • 20
    Greenwald RA, Golub LM, Lavieties NS, Ramamurthy NS, Gruber B, Laskin RS, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987; 14: 2832.
  • 21
    Greenwald RA, Moak SA, Golub LM. Low dose doxycycline inhibits pyridinolone excretion in selected patients with rheumatoid arthritis. Ann N Y Acad Sci 1994; 732: 41921.
  • 22
    Nordstrom D, Lindy O, Lauhio A. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 1998; 17: 17580.
  • 23
    Schumacher HR, Arayssi T, Branigan P, Gerard H, Klippel J, Pando J, et al. Surveying for evidence of synovial chlamydia trachomatis by polymerase chain reaction: a study of 411 synovial biopsies and synovial fluids [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S270.
  • 24
    Van der Heiden IM, Wilbrink B, Schouls LM, Breedveld FC, Tak PP. Detection of mycobacterial species in joint samples from patients with arthritis by PCR [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S271.
  • 25
    Eerola E, Möttönen T, Hannonen P, Luukkainen R, Kantola I, Vuori K, et al. Intestinal flora in early rheumatoid arthritis. Br J Rheumatol 1994; 33: 10308.
  • 26
    Bradley SM, Neumann VC, Barr K, Troughton PR, Astbury C, Bird HA, et al. Sequential study of bacterial antibody levels and faecal flora in rheumatoid arthritis patients taking sulphasalazine. Br J Rheumatol 1993; 32: 6838.
  • 27
    Neumann VC, Shinebaum R, Cooke EM, Wright V. Effects of sulphasalazine on faecal flora in patients with RA: a comparison with penicillamine. Br J Rheumatol 1987; 26: 3347.
  • 28
    Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline: report of 13 patients and review of the literature. Arch Dermatol 1996; 132: 9349.
  • 29
    Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, et al. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 1994; 370: 5557.
  • 30
    McGeehan GM, Becherer JD, Bast RC, Boyer CM, Champion B, Connolly KM, et al. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 1994; 370: 55861.